Novo Nordisk Pledges To Limit Drug Price Increases
Danish drugmaker Novo Nordisk A/S has joined Allergan PLC in promising not to raise its drug prices significantly, and said that it will work toward making drug pricing less complicated overall. ...To view the full article, register now.
Already a subscriber? Click here to view full article